Error message

Enter key-codes to unlock Personalized Downloads field is required.

"Thanks to new Multiplicom test kits physicians are able to identify all the genetic mutations of a condition at once, and use this information to initiate the right - personalized - treatment.”

European Society of Human Genetics conference 2017 (ESHG)

Multiplicom, now part of Agilent Technologies, will be present at the 50th Anniversary of the European Human Genetics Conference (ESHG) 2017 from May 27 – 30 in Copenhagen, Denmark. We would like to invite to our booth no. 662 and to our symposium on Sunday, 28 May from 3.00 - 4.30 PM in room Belgrade. 

Meet our team!

Come to our booth no. 662 and meet our team in person for a demonstration of our new Reporter software. Discover how we can help guide your lab towards better results. Every step of the way. 

Our symposium

Multiplicom, part of Agilent technologies, provides your lab with a broad range of Next-Generation Sequencing solutions, which guide you towards the most reliable results. During our Symposium on Sunday, 28 May from 3.00 - 4.30 PM, we will be talking about how we make a difference in genetic diagnostics. One of our key speakers is Orlando Diez from Vall D’Hebron University Hospital (Spain). He will explain the diverse spectrum of causal mutations in hereditary cancer families and show some remarkable results. Furthermore, Katrien De Mulder from Sint-Lucas Ghent (Belgium) will elaborate on how their lab has implemented NIPT by using the Clarigo solutions. Last but not least Loubna Nachate from the Institut Jean-Godinot in Reims (France) will be talking about how the new Reporter software ensures the correct analysis and enables quality control from sample to results. 


  • BRCA MASTR Dx and MASTR Reporter: a tester experience)

Loubna Nachate - Institut Jean-Godinot, Reims, France

  • Diverse spectrum of causal mutations in hereditary cancer families

Dr. Orland Diez – Val d’Hebron, Institute of Oncology, Barcelona, Spain

  • Clarigo: a decentralized NIPT solution

Dr. Katrien De Mulder – General hospital Sint-Lucas, Ghent, Belgium





Our Poster Abstract

During the ESHG, we will be presenting our poster abstract P14.008D titled 'Integrated diagnostic solution for routine testing of mutations in BRCA1 and BRCA2 with the BRCA MASTR plus Dx assay'. Come for a live presentation to our poster on Monday, 29 May 2017 from 4.45 - 5.45 PM!



Click here for more information on the ESHG 2017.